These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19546361)

  • 21. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption.
    Valdivieso E; Mejías F; Torrealba C; Benaim G; Kouznetsov VV; Sojo F; Rojas-Ruiz FA; Arvelo F; Dagger F
    Acta Trop; 2018 Jul; 183():36-42. PubMed ID: 29604246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
    Seifert K; Croft SL
    Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of
    Özbilgin A; Çavuş İ; Kaya T; Yıldırım A; Harman M
    Turkiye Parazitol Derg; 2020 Mar; 44(1):12-16. PubMed ID: 32212583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antileishmanial activity of drug infused mini-agar plates on Leishmania donovani promastigotes.
    Muniaraj M; Sinha PK; Das P
    Trop Biomed; 2010 Dec; 27(3):657-61. PubMed ID: 21399608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.
    Escobar P; Matu S; Marques C; Croft SL
    Acta Trop; 2002 Feb; 81(2):151-7. PubMed ID: 11801222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models.
    Dube A; Singh N; Sundar S; Singh N
    Parasitol Res; 2005 Jun; 96(4):216-23. PubMed ID: 15868188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
    Shimony O; Jaffe CL
    J Microbiol Methods; 2008 Oct; 75(2):196-200. PubMed ID: 18573286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs.
    Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L
    Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania donovani: assessment of leishmanicidal effects of herbal extracts obtained from plants in the visceral leishmaniasis endemic area of Bihar, India.
    Singh SK; Bimal S; Narayan S; Jee C; Bimal D; Das P; Bimal R
    Exp Parasitol; 2011 Feb; 127(2):552-8. PubMed ID: 21070771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani.
    Tegazzini D; Díaz R; Aguilar F; Peña I; Presa JL; Yardley V; Martin JJ; Coteron JM; Croft SL; Cantizani J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3524-32. PubMed ID: 27021313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
    Hendrickx S; Eberhardt E; Mondelaers A; Rijal S; Bhattarai NR; Dujardin JC; Delputte P; Cos P; Maes L
    J Antimicrob Chemother; 2015 Nov; 70(11):3023-6. PubMed ID: 26253089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
    Gebre-Hiwot A; Tadesse G; Croft SL; Frommel D
    Acta Trop; 1992 Aug; 51(3-4):237-45. PubMed ID: 1359751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
    Van den Kerkhof M; Mabille D; Chatelain E; Mowbray CE; Braillard S; Hendrickx S; Maes L; Caljon G
    Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):81-86. PubMed ID: 29425734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
    Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes.
    Paape D; Bell AS; Heal WP; Hutton JA; Leatherbarrow RJ; Tate EW; Smith DF
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3363. PubMed ID: 25522361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth of Leishmania donovani amastigotes in the continuous human macrophage cell line U937: studies of drug efficacy and metabolism.
    Looker DL; Martinez S; Horton JM; Marr JJ
    J Infect Dis; 1986 Aug; 154(2):323-7. PubMed ID: 3014012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental induction of paromomycin resistance in antimony-resistant strains of L. donovani: outcome dependent on in vitro selection protocol.
    Hendrickx S; Inocêncio da Luz RA; Bhandari V; Kuypers K; Shaw CD; Lonchamp J; Salotra P; Carter K; Sundar S; Rijal S; Dujardin JC; Cos P; Maes L
    PLoS Negl Trop Dis; 2012; 6(5):e1664. PubMed ID: 22666513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.